AVAI
Atlas Venture Associates IX Portfolio holdings
AUM
$11.8M
This Quarter Return
+17.06%
1 Year Return
-58.35%
3 Year Return
-89.8%
5 Year Return
-87.69%
10 Year Return
–
AUM
$227M
AUM Growth
+$227M
(+72%)
Cap. Flow
+$68.4M
Cap. Flow
% of AUM
30.09%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
2
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
SURF
Surface Oncology, Inc. Common Stock
SURF
|
$75.8M |
| 2 |
CBLK
Carbon Black, Inc. Common Stock
CBLK
|
$4.71M |
Top Sells
| 1 |
Intellia Therapeutics
NTLA
|
$12.1M |
Sector Composition
| 1 | Healthcare | 97.06% |
| 2 | Technology | 2.07% |
| 3 | Communication Services | 0.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SURF
1
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $75.8M | 33.35% | +4,645,453 | New | +$75.8M |
|
|
2
Intellia Therapeutics
NTLA
$1.22B
| $50.3M | 22.12% | 1,836,810 -442,978 | -19% | -$12.1M |
|
3
Cogent Biosciences
COGT
$1.69B
| $48.2M | 21.23% | 3,361,535 | – | – |
|
4
Synlogic
SYBX
$17M
| $26.1M | 11.47% | 2,651,963 | – | – |
|
5
Spero Therapeutics
SPRO
$116M
| $20.2M | 8.89% | 1,376,968 | – | – |
|
|
CBLK
6
DELISTED
Carbon Black, Inc. Common Stock
CBLK
| $4.71M | 2.07% | +181,273 | New | +$4.71M |
|
7
Snap
SNAP
$12.1B
| $1.97M | 0.87% | 150,160 | – | – |
|